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Available online 23 December 2015 Green leafy vegetable is one of the major cuisines in Southern Nigeria and they are not only consumed for their 
palatability, but also for their nutritional and medicinal properties as reported in folklore. Notable among them 
are afang (Gnetum africanum), editan (Lasianthera africana) and utazi (Gongronema latifolium). In this study, 
we investigated the effect of aqueous extracts from afang, editan and utazi leaves on cholinesterases [acetylcho­
linesterase (AChE) and butyrylcholinesterase (BChE)] and monoamine oxidase (MAO) activities. Fe2+ chelating 
abilities were also determined as an assessment of their neuroprotective potentials in vitro. We also assayed for 
their total phenol contents while the constituent phenolics were characterized using high performance liquid 
chromatography coupled with diode array detector (HPLC-DAD). The results revealed that the extracts inhibited 
AChE, BChE and MAO activities and also chelated Fe2+ in concentration dependent manner. The HPLC-DAD char­
acterization showed that gallic, caffeic and ellagic acids and rutin were the dominant phenolic compounds in the 
extracts; nevertheless, utazi had the highest distribution of identiﬁed phenolics while afang had the least. The 
ability of the aqueous extracts of the vegetables to inhibit key enzymes (AChE, BChE and MAO) relevant to neu­
rodegeneration, as well chelate metal ion could help suggest their possible neuroprotective properties. These 
vegetables could be use as dietary intervention in the management of neurodegenerative diseases such as 
Alzheimer's and Parkinson's diseases. 






Phenolics 1. Introduction 
Neurodegenerative diseases such as Alzheimer's disease (AD) and 
Parkinson's disease (PD) are pathologies of multiple etiologies. Several 
evidences lay credence to the decline in the brain neurotransmitters 
such as acetylcholine (ACh) and neuroactive amine, as well as oxidative 
stress induced by accumulation of metal ions in the brain as some of the 
key factors in the pathogenesis and progression of these diseases [1]. It  
has therefore become imperative to develop multidimensional thera­
peutic approach at the prevention and management of these diseases 
by focusing attention on these key etiological factors. In this regard, cho­
linesterase and monoamine oxidase inhibitors, as well as antioxidant 
therapy, have been the focus of drug design [1,2]; nevertheless, the im­
portance of dietary interventions as complementary approach at pre­
vention and management of these diseases cannot be overemphasized. 
Cholinergic neurons make use of ACh as neurotransmitter which is 
rapidly hydrolyzed by cholinesterases after its release to the synaptive 
cleft [3,4]. Therefore, cholinesterase inhibitors such as galantamine 
and physostigmine have been designed for therapeutic management na).
 
bH. This is an open access article unof AD [5]. The activity of Monoamine oxidase (MAO) involves in the 
breakdown of monoamine neurotransmitters [6]. Due to the important 
role these neurotransmitters play in neuronal function, MAO has be­
come strategic in the management of several neurodegenerative 
diseases [6,7]. 
Green leafy vegetables form major constituent of local diets 
in Southern Nigeria. They are not only desired for their nutritional ben­
eﬁts, but also for their medicinal properties as reported in folklore. 
Notable among them are Gnetum africanum, Lasianthera africana and 
Gongronema latifolium. G. africanum is a leafy vegetable desired in differ­
ent African countries and especially south-eastern Nigeria (where it is 
commonly referred to as afang) for its nourishment and medicinal prop­
erties [8,9]. L. africana is known as ‘editan’ among the south-eastern 
Nigerians and it is well known for its nutritional and medical beneﬁts 
[10]. It has been used traditionally for treatment of various diseases 
such as fever, ulcer and diabetes [11]. Utazi  (G. latifolium) is another 
vegetable that is well desired for its nutritive and medicinal properties. 
Its leaf is consumed as spice and in preparation of soups and stews [12]. 
Furthermore, the hypolipidermic, hyperglycemic, anti-inﬂamatory and 
antioxidant properties of this vegetable has been previously reported 
[13,14]. In this present study, we investigated the effect of aqueous 
extracts of afang, editan and utazi leaves on cholinesterases (ChEs) der the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 
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Fig. 2. Percentage butyrylcholinesterase (BChE) inhibitory effect of aqueous extracts of 
Gnetum africanum (Afang), Lasianthera africana (Editan) and Gongronema latifolium 
(Utazi) leaves. Bars not sharing a common superscript letter are signiﬁcantly different at 
P b 0.05. 
 and MAO activities. Phenolic constituents of the vegetables were also 
characterized using HPLC-DAD. The ﬁndings of this study are expected 
to shed some light on possible neuroprotective properties of these 
vegetables. 
2. Materials and methods 
2.1. Sample collection and preparation of the extracts 
Fresh sample of afang, editan and utazi were harvested from local 
farmland in Uyo, Nigeria, during the raining season (June) of 2013. 
The samples were identiﬁed and authenticated at Forest Research 
Institute of Nigeria (FRIN), Ibadan, Nigeria. The leaves were plucked 
from its trunk, rinsed under running tap water and dried for twenty 
days at room temperature (under shade) to constant weight. The 
dried leaves were pulverized using the method of Mukhtar and Turkur 
[15]. Thereafter, 0.5 g of each pulverized samples was extracted with 
100 mL of distilled water and was ﬁltered with Whatman no. 1 ﬁlter 
paper. The ﬁltrate was kept in the refrigerator (≤40C) for subsequent 
analysis. 
2.2. Chemicals and reagents 
Chemicals and reagents used such as gallic acid, quercetin, Folin– 
Ciocalteau's reagent, semicarbazide and benzylamine, acetylthiocholine 
and butyrylthiocholine iodide were procured from Sigma-Aldrich, Inc., 
(St Louis, MO); dinitrophenyl hydrazine (DNPH) from ACROS Organics 
(New Jersey, USA), methanol and acetic acid were sourced from BDH 
Chemicals Ltd., (Poole, England). All other chemicals were of analytical 
grade while the water used for all analysis was glass distilled 
2.3. Enzyme assays 
2.3.1. Cholinesterases inhibition assay 
The acetylcholinesterase (AChE) activity was determined in a reac­
tion mixture containing 200 μL of AChE solution (EC 3.1.1.7) in 0.1 M 
phosphate buffer, pH 8.0, 100 μL of a solution of 5,5′-dithio-bis(2­
nitrobenzoic) acid (DTNB) 3.3 mM in 0.1 M phosphate buffered solu­
tion, pH 7.0, containing NaHCO3 (6 mM), extracts (0–100 μL) and 
500 μL of phosphate buffer, pH 8.0. After incubation for 20 min at 
25 °C, 100 μL of 0.05 mM acetylthiocholine iodide was added as the sub­
strate. AChE activity was determined by monitoring changes in the ab­
sorbance at 412 nm for 3 min. Hundred microliter of 
butyrylthiocholine iodide was used as a substrate to assay for BChE ac­
tivity, while all the other reagents and conditions remained the same Fig. 1. Percentage acetylcholinesterase (AChE) inhibitory effect of aqueous extracts of 
Gnetum africanum (Afang), Lasianthera africana (Editan) and Gongronema latifolium 
(Utazi) leaves. Bars not sharing a common superscript letter are signiﬁcantly different at 
P b 0.05. [16]. The percentage inhibitory effect of the extracts on AChE and 
BChE activities was subsequently calculated as: 
Percentage Inhibition ¼ ½ðAbsre f −AbextÞ=Absre f l * 100 
Where, Absref is the absorbance without sample and Absextr is the 
absorbance of the extract. 
2.3.2. MAO inhibitory assay 
The effect of the extracts on MAO activity was measured according 
to a previously reported method [17], with slight modiﬁcation. In 
brief, the mixture contained 0.025 M phosphate buffer (pH 7.0), 
0.0125 M semicarbazide, 10 mM benzylamine and 75 μL of MAO solu­
tion (EC 1.4.3.4) and 0–100 μL of the extracts. After 30 min, acetic acid 
was added and boiled for 3 min water bath followed by centrifugation. 
The resultant supernatant (1 mL) was mixed with equal volume of 2,4­
DNPH and 1.25 mL of benzene (absolute) was added after 10 min of 
incubation at room temperature. After separating the benzene layer, 
equal volume of 0.1 N NaOH was added. Alkaline layer was decanted 
and heated at 80oC for 10 min. The orange–yellow color developed 
was measured at 450 nm in a spectrophotometer. The percentage 
inhibitory effect of the extracts on MAO activity was subsequently 
calculated as: 
Percentage Inhibition ¼ ½ðAbsre f −AbextÞ=Absre f l * 100 
Where, Absref is the absorbance without sample and Absextr is the 
absorbance of the extract. Fig. 3. Percentage monoamine oxidase (MAO) inhibitory effect of aqueous extracts of 
Gnetum africanum (Afang), Lasianthera africana (Editan) and Gongronema latifolium 
(Utazi) leaves. Bars not sharing a common superscript letter are signiﬁcantly different at 
P b 0.05. 
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Table 1 
EC50 values for cholinesterase (AChE and BChE) and monoamine oxidase (MAO), inhibi­
tion as well as Fe2+ chelating ability of Gnetum africanum (afang), Lasianthera africana 
(editan) and Gongronema latifolium (utazi) leaf extracts. 
EC50 (μg/mL) 
Afang Editan Utazi 
AChE 8.36 ± 0.03c 7.86 ± 0.02b 7.00 ± 0.02a 
BChE 8.18 ± 0.03c 7.82 ± 0.02b 6.93 ± 0.08a 
MAO 1.16 ± 0.04b 1.03 ± 0.08a 1.13 ± 0.03a,b 
Fe2+ chelation 0.68 ± 0.04b 0.48 ± 0.06a 0.49 ± 0.03a 
Results are expressed as mean ± standard deviations (SD) of triplicate experiments. Aver­
ages values down each row with different superscript letters are signiﬁcantly different (P b 
0.05). 
Table 2 
Total phenol and ﬂavonoid contents of Gnetum africanum (afang), Lasianthera africana 
(editan) and Gongronema latifolium (utazi) leaf extracts. 
Total phenol⁎ Total ﬂavonoid⁎⁎ 
Afang 11.36 ± 1.47a 10.31 ± 3.20a 
Editan 17.70 ± 0.83b 15.54 ± 1.67a 
Utazi 18.12 ± 0.01b 15.47 ± 3.75a 
Values represent means ± standard deviation of triplicate experiments.
 
Values with the same superscript letter along the same column are not signiﬁcantly differ­
ent (P N 0.05)
 
⁎ mgGAE (Gallic Acid Equivalent)/g dry weight of sample. 
⁎⁎ mgQAE (Quercetin Equivalent)/g dry weight of sample. 2.4. Metal chelation assay 
The metal (Fe2+) chelating ability of the extracts was determined 
using the method of Puntel et al. [18]. Freshly prepared 500 μM FeSO4 
(150 μL) was added to a reaction mixture containing 168 pl 0.1 M Tris 
- HCl (pH 7.4), 218 μL  of  saline and  the extracts  (0  - 25  μL). The reaction 
mixture was incubated for 5 min before the addition of 13 μL 0.25% 1, 
10-phenanthroline (w/v) solution. The absorbance was measured at 
510 nm in a spectrophotometer and the Fe2+  chelating ability was 
subsequently calculated. 2.5. Phytoconstituent analysis 
2.5.1. Determination of total phenol content 
The total phenol content of the extracts was determined according 
to the method of Singleton et al. [19]. Brieﬂy, appropriate dilutions of 
the extracts (5 mg/mL) was oxidized with 2.5 mL 10% Folin­
Ciocalteau's reagent (v/v) and neutralized with 2.0 mL of 7.5% sodium 
carbonate. The reaction mixture was incubated for 40 min at 45 °C 
and the absorbance was measured at 765 nm in the spectrophotometer. 
The total phenol contents were subsequently calculated as gallic acid 
equivalent (GAE) based on dry weight of the sample. 2.5.2. Determination of total ﬂavonoid content 
The total ﬂavonoid content of the extracts was determined using the 
method of Meda et al. [20] with slight modiﬁcations. Five hundred 
microliter of appropriately diluted extracts (5 mg/mL) was mixed 
with 0.5 mL methanol (absolute), 50 μL of 10% AlCl3, 50  μL of 1 mol/L 
potassium acetate and 1.4 mL of distilled water. The reaction mixture 
was incubated at room temperature for 30 min and the absorbance 
was measured at 415 nm in the spectrophotometer. Total ﬂavonoid 
content was expressed as quercetin equivalent (QE) on dry weight of 
sample basis. Fig. 4. Percentage Fe2+ chelating ability of aqueous extracts of Gnetum africanum (Afang), 
Lasianthera africana (Editan) and Gongronema latifolium (Utazi) leaves. Bars not sharing a 
common superscript letter are signiﬁcantly different at P b 0.05. 2.5.3. Quantiﬁcation of compounds by HPLC-DAD 
Reverse phase chromatographic analyses were carried out under 
gradient conditions using C18 column (4.6 mm x 150 mm) packed 
with 5 μm diameter particles; the mobile phase was water containing 
1% formic acid (A) and acetonitrile (B), and the composition gradient 
was: 13% of B until10 min and changed to obtain 20%, 30%, 50%, 60%, 
70%, 20% and10% B at 20, 30, 40, 50, 60, 70 and 80 min, respectively, 
following the method described by Kamdem et al. [21] with slight 
modiﬁcations. The vegetable (afang, editan and utazi) extracts and 
mobile phase were ﬁltered through 0.45 μm membrane ﬁlter 
(Millipore) and then degassed by ultrasonic bath prior to use, the 
extracts were analyzed at a concentration of 20 mg/mL. The ﬂow rate 
was 0.7 mL/min, injection volume 50 μl and the wavelength were 254 
for gallic acid, 280 for catechin, 325 nm for chlorogenic, caffeic 
and ellagic acids, and 365 nm for quercetin, quercitrin, isoquercitrin, 
rutin and kaempferol. All the samples and mobile phase were ﬁltered 
through 0.45 μm membrane ﬁlter (Millipore) and then degassed by 
ultrasonic bath prior to use. Stock solutions of standards references 
were prepared in the HPLC mobile phase at a concentration range 
of 0.030 – 0.250 mg/mL for kaempferol, quercetin, quercitrin, 
isoquercitrin, rutin and catechin; and 0.050 – 0.450 mg/mL for ellagic, 
gallic, caffeic and chlorogenic acids. Chromatography peaks were 
conﬁrmed by comparing its retention time with those of reference 
standards and by DAD spectra (200 to 500 nm). Calibration curve 
for gallic acid: Y = 12618x + 1196.2 (r = 0.9996); chlorogenic acid: 
Y = 11953x + 1367.5 (r = 0.9998); ellagic acid: Y = 
12743x + 1246.3 (r = 0.9991); catechin: Y = 13089x + 1257.9 (r = 
0.9995); caffeic acid: Y = 12053x + 1275.9 (r = 0.9997); quercitrin: 
Y = 13165x + 1205.7 (r = 0.9999); isoquercitrin: Y = 
12736x + 1365.1 (r = 0.9993); rutin: Y = 13983x + 1171.3 (r = 
0.9998); quercetin: Y = 13165x + 1292.5 (r = 0.9996) and 
kaempferol: Y = 12539x + 1183.0 (r = 0.9997). All chromatography 
operations were carried out at ambient temperature and in triplicate. 
The limit of detection (LOD) and limit of quantiﬁcation (LOQ) were 
calculated based on the standard deviation of the responses and the 
slope using three independent analytical curves. LOD and LOQ were 
calculated as 3.3 and 10 σ/S, respectively, where σ is the standard devi­
ation of the response and S is the slope of the calibration curve [22]. 
2.6. Data analysis 
The results of three (3) replicate experiments were pooled and 
expressed as meanstandard deviation (SD). One-way analysis of 
variance (ANOVA) was used to analyze the mean and the post hoc treat­
ment was performed using Duncan multiple test [25]. Signiﬁcance was 
accepted at P b 0.05. EC50 (extract concentration causing 50% effective­
ness) were calculated with GraphPad Prism version 5.00 for Windows. 
3. Result and discussion 
We commenced this study by investigating the effect of aqueous ex­
tracts of afang, editan and utazi on AChE and BChE activities (in vitro). 
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Fig. 5. High performance liquid chromatography proﬁle of phenolic acids and ﬂavonoids of (a) Gnetum africanum (afang), (b) Lasianthera africana (editan) and (c) Gongronema latifolium 
(utazi) leaf extracts. For Afang: Gallic acid (peak 1), catechin (peak 2), caffeic acid (peak 3), epicatechin (peak 4), ellagic acid (peak 5), orientin (peak 6), rutin (peak 7) and quercitrin (peak 
8). For editan and utazi: Gallic acid (peak 1), catechin (peak 2), chlorogenic acid (peak 3), caffeic acid (peak 4), ellagic acid (peak 5), rutin (peak 6), quercitrin (peak 7), isoquercitrin (peak 
8), quercetin (peak 9) and kaempferol (peak 10). The results as presented in Figs. 1 and 2 showed that the extracts 
inhibited AChE and BChE activities in concentration dependent manner 
(6.0 - 17.0 μg/mL). Furthermore, their EC50 values revealed that utazi 
(AChE = 7.00 ± 0.02 μg/mL; BChE = 6.93 ± 0.08 μg/mL) had the 
highest inhibitory effect, while afang had the least (AChE = 8.36 ± 
0.03 μg/mL; BChE = 8.18 ± 0.03 μg/mL). These agree with previous 
ﬁndings that plant extracts have cholinesterase inhibitory properties 
which have been largely linked to their constituent polyphenols. In an 
earlier study from our research laboratory, we reported that phenolic 
compounds from some tropical leafy vegetables displayed potential 
neuroprotective properties by inhibiting cholinesterases' activities 
in vitro [26]. Similarly, phytoconstituents of Satureja thymbra L also 
displayed cholinesterase inhibitory properties as reported by Öztürk 
[27]. We  also  ﬁnd an agreement between our ﬁndings in this study 
and that of Ahmad et al. [28], who reported the AChE and BChE inhibi­
tory effects of Rumex hostatus. 
Increased activity of brain acetylcholinesterase facilitates rapid 
hydrolysis of ACh neurotransmitter, thus impairing the cholinergic neu­
ronal function [5]. This has been shown to be the major risk factor in the 
development and progression of dementia [5]. Therefore, with the 
growing interest in cholinesterase inhibitors as effective therapy for Table 3 
Phenolics and ﬂavonoids composition of Gnetum africanum (afang), Lasianthera africana 
(editan) and Gongronema latifolium (utazi) leaf extracts. 
Afang Editan Utazi 
Compounds mg/g dry weight of sample 
Gallic acid 1.69 ± 0.01a 14.53 ± 0.02a 45.19 ± 0.01a 
Catechin 0.48 ± 0.03b 25.90 ± 0.01b 19.63 ± 0.03b 
Caffeic acid 3.07 ± 0.01c 59.97 ± 0.03c 110.85 ± 0.03d 
Epicatechin 3.11 ± 0.02c – – 
Ellagic acid 4.95 ± 0.02d 31.16 ± 0.01d 82.63 ± 0.01e 
Orientin 5.73 ± 0.01e – – 
Rutin 9.04 ± 0.01f 26.08 ± 0.03b 31.45 ± 0.02f 
Quercitrin 5.52 ± 0.03g 24.30 ± 0.03b 32.09 ± 0.01f 
Isoquercitrin - 13.67 ± 0.01a 17.53 ± 0.01b 
Quercetin - 42.98 ± 0.03e 54.68 ± 0.03c 
Kaempferol - 26.15 ± 0.01a 83.71 ± 0.02e 
Chlorogenic acid - 58.23 ± 0.01c 53.71 ± 0.01c 
Results are expressed as mean ± standard deviations (SD) of three determinations. the management of neurodegenerative diseases, especially AD and PD, 
coupled with the ﬁnancial burden of accessing available therapeutic 
drugs, dietary sources of ChEs inhibitors such as the understudied 
vegetables could be a respite as complementary approach in the 
prevention/management of these diseases. In addition, higher inhibi­
tion of BChE activity is often desirable in humans. This is because BChE 
represents the predominant cholinesterase in late stage AD in humans 
[29,30]. In addition, BChE inhibition could slow down the production 
of neurotoxic plaques which is also a high risk factor in the development 
of AD [31,32]. Therefore, it is of interest that the extracts showed higher 
BChE inhibitory effect than AChE. Previous ﬁndings have also reported 
the ability of plant extracts to inhibit BChE activity better than AChE 
(in vitro) [33,34]. 
Impairment of the monoaminergic neurotransmission through rapid 
oxidation of monoamine neurotransmitters by MAO has been implicat­
ed in the pathogenesis and progression of several neurodegenerative 
diseases, especially PD and AD [35]. Therefore, inhibition of MAO activ­
ities offers useful therapeutic strategy in the management of these dis­
eases [7]. In addition, previous ﬁndings have reported that plant 
extracts are potent inhibitors of MAO activity. In lieu of these, we further 
investigated the effects of the extracts on MAO activities. The result 
(Fig. 3) showed that all extracts inhibited MAO activity (in vitro) in con­
centration dependent manner (0.17 - 0.67 μg/mL). Considering the ex­
tracts inhibitory effectiveness as revealed by the EC50 values (Table 1), 
there was no signiﬁcant difference (P N 0.05) in the inhibitory effects 
of the extracts (editan = 1.03 ± 0.08 μg/mL; utazi = 0.13 ± 
0.03 μg/mL; afang = 0.16 ± 0.04 μg/mL). These ﬁndings also agree 
with earlier studies on the MAO inhibitory properties of plant phyto­
chemicals; Zhi et al. [6], reported that phytoconstituents from leaf of 
Desmodium elegans are potent MAO inhibitor, while Ademosun et al. 
[33], reported MAO inhibitory properties of essential oils from peel 
and seed of sweet orange as part of their neuroprotective properties. 
Therefore, the ability of the extracts in this study to inhibit MAO activity 
could be another mechanism contributing to their neuroprotective 
properties, and could be essential for the prevention and management 
of neurodegeneration. 
Accumulation of iron in several regions of the brain has been associ­
ated with the development of neurodegeneration and Parkinson-like 
symptoms [36]. Furthermore, oxidative stress induced by iron has 
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Table 4 
Pearson correlation coefﬁcients between enzymes' (AChE, BChE and MAO) inhibition by the vegetable extracts and their phytoconstituents as identiﬁed by HPLC-DAD. 
AChE BChE MAO GAL CAT CAF EPI ELL ORI RUT QUE ISO QUR KAE CHL 
AChE 1 .992⁎⁎ .807⁎⁎ .442 .311 .449 -.380 .445 -.379 .425 .432 .421 .421 .439 .369 
BChE .992⁎⁎ 1 .855⁎⁎ .374 .219 .366 -.286 .374 -.285 .333 .342 .329 .329 .370 .268 
MAO .807⁎⁎ .855⁎⁎ 1 -.054 .115 -.007 -.081 -.046 -.079 .040 .029 .043 .045 -.054 .090 
GAL = Gallic acid; CAT = Catechin; CAF = Caffeic acid; EPI = Epicatechin; ELL = Ellagic acid; ORI = Orientin; RUT = Rutin; QUE = Quercitrin; 
ISO = Isoquercitrin; QUR = Quercetin; KAE = Kaempferol; CHL = Chlorogenic acid 
n = number of treatment = 9 
⁎⁎ Correlation is signiﬁcant at the 0.01 level (2-tailed). 
 
 been established via initiation of the fenton reaction, producing hydrox­
yl radicals [37]. Hydroxyl radicals are potent at inducing oxidative dam­
age to DNA, lipids and proteins, thus propagating neuronal cell death 
[1]. Therefore, reducing excessive brain accumulation of iron via chela­
tion could be another positive approach at prevention and management 
of neurodegenerative diseases. Therefore, as presented in Fig. 4, all
extracts chelated Fe2+  concentration dependently (0.1–0.5 μg/mL). 
The chelating effectiveness of the extracts as revealed by their EC50 
values (Table 1), showed that editan (0.48 ± 0.06 μg/mL) and utazi 
(0.49 ± 0.03 μg/mL) showed no signiﬁcant difference (P N 0.05) in 
their chelating abilities but were higher (P b 0.05) than that of afang 
(0.68 ± 0.04 μg/mL). It is therefore suggestive that the ability of the 
extracts to chelate Fe2+ could also contribute to their neuroprotective 
properties. 
Informed by the fact that previous ﬁndings have shown that 
phenolic constituents of several plant extracts can modulate the activi­
ties of enzymes of physiological importance as well as prevent oxidative 
stress, we further determined the total phenol and ﬂavonoid contents of 
the extracts. Therefore, as presented in Table 2, the total phenol content 
of the extracts ranged from 11.36 ± 1.47 (afang) to 18.12 ± 0.01 mg 
GAE/g (utazi). Also, the total ﬂavonoid contents ranged from 10.31 ± 
3.20 (afang) to 15.54 ± 1.67 mg/QAE/g (editan). However, with the 
understanding of the limitations of the Folin-Ciocalteau method of 
quantifying phenol contents in the plant extracts [38,39], we employed 
the use of HPLC-DAD to have a clearer quantitative distribution of poly-
phenols present in the extracts. The results (Fig. 5 and Table 3) showed  
that gallic, caffeic and ellagic acid and rutin are the dominant polyphe­
nols in the extracts. Nevertheless, utazi had the highest distribution of 
identiﬁed phenols while afang had the least. In addition, according to 
the Pearson correlation coefﬁcients between these characterized phe­
nolic compounds and the AChE, BChE and MAO inhibitory effects of 
the extracts (Table 4), all the phenolic phytochemicals had a good cor­
relation to the enzyme inhibitory effects. Nevertheless, caffeic acid had 
the highest correlation to the AChE inhibitory effect of the extracts, gal­
lic and ellagic acid have the highest correlations to the BChE inhibitory 
effects while catechin had the highest correlation to the MAO inhibitory 
effects of the extracts. 
The ability of plant phenolic extracts to show potential therapeutic 
properties has been well reported [40]. Previous studies  have  also
shown that plant phenolic-rich extracts showed potential neuroprotec­
tive properties by inhibiting key enzymes relevant to neurodegenera­
tion as well as exhibiting antioxidant properties [41]. Oboh et al., [26] 
had earlier reported that phenolic-rich extracts from some tropical 
leafy vegetables displayed potential neuroprotective properties by 
inhibiting ChEs activities and exhibiting antioxidant properties in vitro. 
Similarly, Senol et al., [42] reported ChEs inhibitory and antioxidant 
properties of aerial parts of thirty three taxa of Scutellaria species from 
Turkey relevant to their neuroprotective properties. Therefore, we 
could suggest that the phenolic contents of the extracts in this study 
could be responsible for their neuroprotective properties. The fact that 
the characterized phenolic phytochemicals in the extracts correlated 
well with their enzyme inhibitory effects also support the fact that 
these phytochemicals could be signiﬁcantly responsible for the observed inhibitory effects. Earlier study from our laboratory [43] re­
ported that caffeic acid and chlorogenic acid inhibited AChE and BChE 
activities in vitro, with caffeci acid producing the signiﬁcantly higher 
inhibitory effects; nevertheless, their combination was reported to pro­
duce antagonistic effects on the enzymes' inhibition. Furthermore, 
Ademosun et al., [44] reported that quercetin had signiﬁcantly higher 
cholinesterase inhibitory effects than its glycosylated form (rutin). 
Therefore, in this study, interactions between the constituent phenolic 
phytochemicals in the extracts could also contribute signiﬁcantly to 
the observed enzyme inhibitory effects. 
4. Conclusion 
The abilities of the aqueous extracts of afang, editan and utazi to 
inhibit key enzymes (AChE, BChE and MAO) relevant to neurodegener­
ation and to chelate Fe2+ (in vitro), could be some of the mechanisms 
underlying their possible neuroprotective properties. These vegetables 
could therefore offer possible dietary intervention in the management 
of neurodegenerative diseases, especially AD and PD. The differential 
distribution of phenolic phytochemicals in these vegetables could also 
explain the difference in their observed biological activities. However, 
in vivo studies on bio-availability of the phenolic compounds isolated 
from the extracts in biological systems, and further clinical trials are 
highly recommended. 
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